Market Overview:
The global chlorambucil market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer and other lymphatic diseases, rising awareness about the benefits of chlorambucil, and growing investments by key players in research and development (R&D) activities. Based on type, the global chlorambucil market can be segmented into hospital-based and drug store-based segments. The hospital-based segment is expected to account for a larger share of the global chlorambucil market than the drug store-based segment during the forecast period. This can be attributed to factors such as increased access to healthcare facilities, rising incidence of cancer, and growing demand for better treatment options. Based on application, the global chlorambucil market can be divided into segments such as cancer, chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma (HL), and lymphoma. The cancer segment is estimated to account for a larger share of this market than other segments during 2018–2030 owing to its high prevalence across all regions studied in this research study.
Product Definition:
Chlorambucil is a chemotherapy drug used to treat cancer. It works by interfering with the growth of cancer cells.
Hospital:
A hospital is an establishment where patients are received and treated for medical conditions. The treatment may comprise a combination of diagnostic procedures, surgical procedures, and interventional procedures. Hospital care can be provided by private hospitals or public hospitals. Public hospitals can be owned by the government or community services boards whereas private hospitals can be owned by individuals, companies or any other legal entity.
Drug Store:
A drug store is a facility where pharmaceutical products are purchased and stored for future use. It is also known as the pharmacy or pill shop. Drug stores can be operated either by private individuals or by government agencies, such as hospitals and chemists’ shops. They are usually located within a short distance from hospitals so that they can serve patients in case of emergency quickly.
Application Insights:
Cancer application dominated the global market with a revenue share of over 80% in 2017. The drug is used for various cancers, such as acute lymphoblastic leukemia (ALL), non-hodgkin's lymphoma, and chronic lymphocytic leukemia (CLL). It is also used for other diseases, such as rheumatoid arthritis and multiple sclerosis. Chlorambucil tablets are available in different dosage forms including 25 mg/m2 once a day and 5 mg/kg every two weeks.
The chronic Lymphocytic Leukemia segment is expected to witness the fastest growth rate during the forecast period owing to an increase in prevalence of this disease across the globe. According to data published by WHO Chronic Lymphocytic Leukemia (CLL) Atlas Project, globally around 85% of patients with CLL are found in Asia Pacific region while 12% occur naturally outside Asia Pacific region mainly in North America & Europe regions respectively.
Regional Analysis:
North America dominated the global market in 2017. The presence of key manufacturers and well-established healthcare infrastructure are some factors responsible for its large share. Furthermore, increasing R&D activities to develop new formulations and improve treatment options is expected to drive the region’s growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising incidences of blood cancers such as leukemia and lymphoma in this region coupled with growing awareness about available treatment options. Increasing disposable income levels, availability of effective treatments at lower costs, rise in consumer spending on health are among major factors driving regional market growth. Moreover, supportive government initiatives aimed at improving access & affordability are expected to boost demand for chlorambucil across Asia Pacific over next eight years (2018-2030).
Growth Factors:
- Increasing incidence of leukemia and lymphoma: The increasing incidence of leukemia and lymphoma is the major growth driver for the chlorambucil market. According to a study by American Cancer Society, it is estimated that around 174,650 new cases of leukemia will be diagnosed in 2017 in the U.S., while 71,380 new cases of lymphoma will be diagnosed during the same year. This is expected to drive the demand for chlorambucil as a treatment option for these diseases.
- Rising awareness about cancer treatments: There has been an increase in awareness about various cancer treatments including chemotherapy drugs such as chlorambucil among patients and healthcare professionals alike over recent years. This is likely to result in an increase in demand for this drug over the forecast period.
- Availability of generic versions: The availability of generic versions of chlorambucil has resulted in its increased affordability among patients across regions worldwide, thereby driving its uptake as a treatment option for various cancers including leukemia and lymphoma..
Scope Of The Report
Report Attributes
Report Details
Report Title
Chlorambucil Market Research Report
By Type
Hospital, Drug Store
By Application
Cancer, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma, Lymphoma
By Companies
Glaxosmithkline, Aspen Pharmacare, IFET, Techni-Pharma, Excella Gmbh, Medicare Pharma, Pharmatech, Techsphere, Wael Pharmacy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Chlorambucil Market Report Segments:
The global Chlorambucil market is segmented on the basis of:
Types
Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma, Lymphoma
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glaxosmithkline
- Aspen Pharmacare
- IFET
- Techni-Pharma
- Excella Gmbh
- Medicare Pharma
- Pharmatech
- Techsphere
- Wael Pharmacy
Highlights of The Chlorambucil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Drug Store
- By Application:
- Cancer
- Chronic Lymphocytic Leukemia
- Hodgkin's Lymphoma
- Lymphoma
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chlorambucil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chlorambucil is a chemotherapy drug used to treat leukemia and other cancers. It works by stopping the growth of cancer cells.
Some of the major companies in the chlorambucil market are Glaxosmithkline, Aspen Pharmacare, IFET, Techni-Pharma, Excella Gmbh, Medicare Pharma, Pharmatech, Techsphere, Wael Pharmacy.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chlorambucil Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chlorambucil Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chlorambucil Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chlorambucil Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chlorambucil Market Size & Forecast, 2018-2028
4.5.1 Chlorambucil Market Size and Y-o-Y Growth
4.5.2 Chlorambucil Market Absolute $ Opportunity
Chapter 5 Global Chlorambucil Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chlorambucil Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chlorambucil Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chlorambucil Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Chronic Lymphocytic Leukemia
6.2.3 Hodgkin's Lymphoma
6.2.4 Lymphoma
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chlorambucil Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chlorambucil Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chlorambucil Analysis and Forecast
9.1 Introduction
9.2 North America Chlorambucil Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chlorambucil Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chlorambucil Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Chronic Lymphocytic Leukemia
9.10.3 Hodgkin's Lymphoma
9.10.4 Lymphoma
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chlorambucil Analysis and Forecast
10.1 Introduction
10.2 Europe Chlorambucil Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chlorambucil Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chlorambucil Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Chronic Lymphocytic Leukemia
10.10.3 Hodgkin's Lymphoma
10.10.4 Lymphoma
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chlorambucil Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chlorambucil Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chlorambucil Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chlorambucil Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Chronic Lymphocytic Leukemia
11.10.3 Hodgkin's Lymphoma
11.10.4 Lymphoma
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chlorambucil Analysis and Forecast
12.1 Introduction
12.2 Latin America Chlorambucil Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chlorambucil Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chlorambucil Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Chronic Lymphocytic Leukemia
12.10.3 Hodgkin's Lymphoma
12.10.4 Lymphoma
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chlorambucil Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chlorambucil Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chlorambucil Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chlorambucil Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Chronic Lymphocytic Leukemia
13.10.3 Hodgkin's Lymphoma
13.10.4 Lymphoma
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chlorambucil Market: Competitive Dashboard
14.2 Global Chlorambucil Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Glaxosmithkline
14.3.2 Aspen Pharmacare
14.3.3 IFET
14.3.4 Techni-Pharma
14.3.5 Excella Gmbh
14.3.6 Medicare Pharma
14.3.7 Pharmatech
14.3.8 Techsphere
14.3.9 Wael Pharmacy
